MOF Panel to Pitch Reference Pricing for Long-Listed Drugs, Price Cut in FY2015

October 9, 2014
A key advisory panel to the finance minister will push the introduction of a reference pricing rule for off-patent branded medicines and the implementation of a market price-based NHI price revision in its budget recommendation for FY2015 beginning in April...read more